Liu S-Y, Tsai I-T, Hsu Y-C. Alcohol-related liver disease: basic mechanisms and clinical perspectives. International journal of molecular sciences. 2021;22(10):5170.

Schwantes‐An TH, Darlay R, Mathurin P, Masson S, Liangpunsakul S, Mueller S, et al. Genome‐wide association study and meta‐analysis on alcohol‐associated liver cirrhosis identifies genetic risk factors. Hepatology. 2021;73(5):1920-31.

Jiang Y, Zhang T, Kusumanchi P, Han S, Yang Z, Liangpunsakul S. Alcohol metabolizing enzymes, microsomal ethanol oxidizing system, cytochrome P450 2E1, catalase, and aldehyde dehydrogenase in alcohol-associated liver disease. Biomedicines. 2020;8(3):50.

Dong-Chen X, Yong C, Yang X, Chen-Yu S, Li-Hua P. Signaling pathways in Parkinson’s disease: molecular mechanisms and therapeutic interventions. Signal transduction and targeted therapy. 2023;8(1):73.

López B, Ravassa S, Moreno MU, José GS, Beaumont J, Gonzalez A, et al. Diffuse myocardial fibrosis: mechanisms, diagnosis and therapeutic approaches. Nature Reviews Cardiology. 2021;18(7):479-98.

Kanda T, Goto T, Hirotsu Y, Masuzaki R, Moriyama M, Omata M. Molecular mechanisms: connections between nonalcoholic fatty liver disease, steatohepatitis and hepatocellular carcinoma. International journal of molecular sciences. 2020;21(4):1525.

Kisseleva T, Brenner D. Molecular and cellular mechanisms of liver fibrosis and its regression. Nature Reviews Gastroenterology & Hepatology. 2021;18(3):151-66.

Malik I, Kelley CP, Wang ET, Todd PK. Molecular mechanisms underlying nucleotide repeat expansion disorders. Nature reviews Molecular cell biology. 2021;22(9):589-607.

Ramos-Tovar E, Muriel P. Molecular mechanisms that link oxidative stress, inflammation, and fibrosis in the liver. Antioxidants. 2020;9(12):1279.

Arjmand B, Khodadoost M, Sherafat SJ, Tavirani MR, Ahmadi N, Tavirani SR. Introducing critical proteins related to liver ischemia/reperfusion injury. 2024.

Jiang CH, Yuan X, Li JF, Xie YF, Zhang AZ, Wang XL, et al. Bioinformatics-based screening of key genes for transformation of liver cirrhosis to hepatocellular carcinoma. Journal of Translational Medicine. 2020;18:1-11.

Wu C, Zhou Y, Wang M, Dai G, Liu X, Lai L, et al. Bioinformatics analysis explores potential hub genes in nonalcoholic fatty liver disease. Frontiers in genetics. 2021;12:772487.

Zamanian-Azodi M, Hajisayah SK, Razzaghi M, Rezaei-Tavirani M. Introducing physical exercise as a potential strategy in liver cancer prevention and development. Gastroenterology and Hepatology From bed to Bench. 2021;14(4):317.

Feng G, Li X-P, Niu C-Y, Liu M-L, Yan Q-q, Fan L-P, et al. Bioinformatics analysis reveals novel core genes associated with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Gene. 2020;742:144549.

Yin H-Q, Kim M, Kim J-H, Kong G, Kang K-S, Kim H-L, et al. Differential gene expression and lipid metabolism in fatty liver induced by acute ethanol treatment in mice. Toxicology and applied pharmacology. 2007;223(3):225-33.

Nanji AA, Miao L, Thomas P, Rahemtulla A, Khwaja S, Zhao S, et al. Enhanced cyclooxygenase-2 gene expression in alcoholic liver disease in the rat. Gastroenterology. 1997;112(3):943-51.

Wang Z, Yao T, Song Z. Involvement and mechanism of DGAT2 upregulation in the pathogenesis of alcoholic fatty liver disease. Journal of lipid research. 2010;51(11):3158-65.

McArthur AG, Hegelund T, Cox RL, Stegeman JJ, Liljenberg M, Olsson U, et al. Phylogenetic analysis of the cytochrome P450 3 (CYP3) gene family. Journal of molecular evolution. 2003;57:200-11.

Strange RC, Spiteri MA, Ramachandran S, Fryer AA. Glutathione-S-transferase family of enzymes. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. 2001;482(1-2):21-6.

Manikandan P, Nagini S. Cytochrome P450 structure, function and clinical significance: a review. Current drug targets. 2018;19(1):38-54.

Villeneuve J-P, Pichette V. Cytochrome P450 and liver diseases. Current drug metabolism. 2004;5(3):273-82.

Fisher CD, Lickteig AJ, Augustine LM, Ranger-Moore J, Jackson JP, Ferguson SS, et al. Hepatic cytochrome P450 enzyme alterations in humans with progressive stages of nonalcoholic fatty liver disease. Drug metabolism and disposition. 2009;37(10):2087-94.

Cederbaum AI. Role of Cytochrome P450 and oxidative stress in alcohol-induced liver injury. Reactive Oxygen Species. 2017;4(11):303-19.

Board PG, Menon D. Glutathione transferases, regulators of cellular metabolism and physiology. Biochimica et biophysica acta (bba)-general subjects. 2013;1830(5):3267-88.

Tew KD, Townsend DM. Glutathione-s-transferases as determinants of cell survival and death. Antioxidants & redox signaling. 2012;17(12):1728-37.

Vairetti M, Di Pasqua LG, Cagna M, Richelmi P, Ferrigno A, Berardo C. Changes in glutathione content in liver diseases: an update. Antioxidants. 2021;10(3):364.

Gant TW. Gene Expression Profiles Associated with Inflammation Fibrosis and Cholestasis in Mouse Liver after Griseofulvin. Environmental Health Perspectives. 2003;111(6):847-8.